Literature DB >> 15692229

Metalloproteinases in development and progression of vascular disease.

H Roger Lijnen1.   

Abstract

Remodeling of the vascular wall plays a role in many physiological processes, but also in the pathogenesis of major cardiovascular diseases such as restenosis and atherosclerosis. Remodeling requires proteolytic activity to degrade components of the extracellular matrix; this can be generated by the matrix metalloproteinase(MMP) system alone or in concert with the fibrinolytic (plasminogen/plasmin) system. Several lines of evidence suggest that the MMP system plays a role in vascular smooth muscle cell migration and neointima formation after vascular injury. In atherosclerotic lesions, active MMPs may contribute to plaque destabilisation by degrading extracellular matrix components, but may also promote aneurysm formation by proteolytic degradation of the elastic lamina. The MMP system may therefore represent a potential therapeutic target for treatment of restenosis or atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15692229     DOI: 10.1159/000083814

Source DB:  PubMed          Journal:  Pathophysiol Haemost Thromb        ISSN: 1424-8832


  23 in total

Review 1.  Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.

Authors:  Jeffrey A Beamish; Ping He; Kandice Kottke-Marchant; Roger E Marchant
Journal:  Tissue Eng Part B Rev       Date:  2010-10       Impact factor: 6.389

2.  Pathology of urethral fibromuscular system related to parturition-induced stress urinary incontinence and TGF-β1/Smad pathway.

Authors:  Guang-Yong Li; Wan-Shou Cui; Feng Zhou; Zhe-Zhu Gao; Hua Xin; Tao Liu; Wei-Ren Li; Yan-Qing Gong; Guang-Yi Bai; Ying-Lu Guo; Zhong-Cheng Xin
Journal:  Mol Cell Biochem       Date:  2012-02-04       Impact factor: 3.396

3.  Activation of arterial matrix metalloproteinases leads to vascular calcification in chronic kidney disease.

Authors:  Neal X Chen; Kalisha D O'Neill; Xianming Chen; Kraiwiporn Kiattisunthorn; Vincent H Gattone; Sharon M Moe
Journal:  Am J Nephrol       Date:  2011-07-23       Impact factor: 3.754

Review 4.  Cardiovascular gene delivery: The good road is awaiting.

Authors:  L P Brewster; E M Brey; H P Greisler
Journal:  Adv Drug Deliv Rev       Date:  2006-07-07       Impact factor: 15.470

5.  Association of MMP-9 gene polymorphisms with nephrolithiasis patients.

Authors:  Atheer Awad Mehde; Wesen Adel Mehdi; Faridah Yusof; Raha Ahmed Raus; Zaima Azira Zainal Abidin; Hamid Ghazali; Azlina Abd Rahman
Journal:  J Clin Lab Anal       Date:  2017-02-15       Impact factor: 2.352

Review 6.  Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder.

Authors:  Nasser Chegini
Journal:  Semin Reprod Med       Date:  2010-04-22       Impact factor: 1.303

7.  Matrix metalloproteinases and risk stratification in patients undergoing surgical revascularisation for critical limb ischaemia.

Authors:  Giovanni De Caridi; Mafalda Massara; Francesco Spinelli; Antonio David; Sebastiano Gangemi; Francesco Fugetto; Raffaele Grande; Lucia Butrico; Roberta Stefanelli; Manuela Colosimo; Stefano de Franciscis; Raffaele Serra
Journal:  Int Wound J       Date:  2015-05-27       Impact factor: 3.315

Review 8.  Caldesmon as a therapeutic target for proliferative vascular diseases.

Authors:  Chi-Ming Hai
Journal:  Mini Rev Med Chem       Date:  2008-10       Impact factor: 3.862

Review 9.  Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm.

Authors:  Faisal Aziz; Helena Kuivaniemi
Journal:  Ann Vasc Surg       Date:  2007-05       Impact factor: 1.466

Review 10.  Digging in the "soil" of the aorta to understand the growth of abdominal aortic aneurysms.

Authors:  John A Curci
Journal:  Vascular       Date:  2009 May-Jun       Impact factor: 1.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.